# Interaction relations
# Express clinically significant drug-drug interactions
# These show when combining safe treatments requires monitoring

relation_type: interacts_with

relations:
  # Diabetes drug interactions
  - source_id: metformin
    target_id: insulin
    strength: moderate
    evidence: "Combination increases hypoglycemia risk; monitor blood glucose closely"

  - source_id: glyburide
    target_id: insulin
    strength: strong
    evidence: "Additive hypoglycemia risk; typically not combined"

  - source_id: glipizide
    target_id: insulin
    strength: strong
    evidence: "Additive hypoglycemia risk; typically not combined"

  - source_id: glyburide
    target_id: metformin
    strength: moderate
    evidence: "Common combination but increases hypoglycemia risk; monitor closely"

  - source_id: glipizide
    target_id: metformin
    strength: moderate
    evidence: "Common combination but increases hypoglycemia risk; monitor closely"

  # Hypertension drug interactions
  - source_id: lisinopril
    target_id: losartan
    strength: strong
    evidence: "Dual RAAS blockade increases hyperkalemia and renal adverse events"

  - source_id: enalapril
    target_id: losartan
    strength: strong
    evidence: "Dual RAAS blockade increases hyperkalemia and renal adverse events"

  - source_id: labetalol
    target_id: nifedipine
    strength: moderate
    evidence: "Additive hypotension and bradycardia; monitor blood pressure"

  - source_id: labetalol
    target_id: amlodipine
    strength: moderate
    evidence: "Additive hypotension and bradycardia; monitor blood pressure"

  # HIV drug interactions
  - source_id: tenofovir
    target_id: metformin
    strength: moderate
    evidence: "Both cleared renally; monitor renal function closely"

  - source_id: dolutegravir
    target_id: metformin
    strength: moderate
    evidence: "Dolutegravir increases metformin levels; consider dose adjustment"

  # Cross-class interactions
  - source_id: metformin
    target_id: lisinopril
    strength: moderate
    evidence: "Both affect renal function; monitor in patients with renal impairment"

  - source_id: metformin
    target_id: losartan
    strength: moderate
    evidence: "Both affect renal function; monitor in patients with renal impairment"

  - source_id: insulin
    target_id: labetalol
    strength: moderate
    evidence: "Beta blockers may mask hypoglycemia symptoms; monitor blood glucose"

  - source_id: glyburide
    target_id: labetalol
    strength: moderate
    evidence: "Beta blockers may mask hypoglycemia symptoms; monitor blood glucose"
